Herbalife (HLF) Surges After Q3 2025 Beat
Herbalife Ltd. (NYSE:HLF) is a global health and wellness company with more than four decades of history built…
Mobile-health Network Solutions (MNDR) Signs $120M MOU to Acquire Two Malaysian AI Data Centers
Mobile-health Network Solutions (NASDAQ:MNDR) is an emerging AI-driven HealthTech company built on a foundation of digital innovation, mobile…
Nano-X Imaging (NNOX) Gains Momentum as 3DR Labs Brings Its AI to 1,800 Providers
Nano-X Imaging Ltd. (NASDAQ:NNOX) is a medical technology company founded with the ambitious mission of transforming global access…
Annovis Bio (ANVS) Raises $6M at $1.50/Share
Annovis Bio Inc. (NYSE:ANVS) headquartered in Malvern, Pennsylvania, is a late-stage clinical drug platform company built on a…
GRI Bio (GRI) Skyrockets 48.72% After NKT Therapy Breakthrough
GRI Bio Inc. (NASDAQ:GRI) is an emerging clinical-stage biotechnology company built on a mission to transform the treatment…
Tyra Biosciences (TYRA): The $274.9M Precision Biotech Betting Big on FGFR3 Breakthroughs in 2026
Tyra Biosciences (NASDAQ:TYRA) is a clinical-stage biotechnology company founded on the mission of applying next-generation precision medicine to…
Mobile-Health Network (MNDR) Soars 83% After $120M AI Data Center Deal
Mobile-Health Network Solutions (NASDAQ:MNDR) has steadily grown into a distinctive presence in the global digital healthcare landscape by…
Nutex Health (NUTX) Posts 220.7% Revenue Surge
Nutex Health Inc. (NASDAQ:NUTX) is a rapidly expanding, physician-driven healthcare management and operations company that specializes in building…
Exact Sciences (EXAS) Soars 25% After Abbott Takeover Rumors
Exact Sciences (NASDAQ:EXAS) is a leading molecular diagnostics company founded in 1995 with a mission to revolutionize the…
Analysts Cut Earnings Estimates for Agios Pharma (AGIO)—But Some Still Target $56–$57
Agios Pharmaceuticals Inc. (NASDAQ:AGIO) is a biopharmaceutical company built on the foundation of pioneering research in cellular metabolism…
Catalyst Pharmaceuticals (CPRX) Smashes Earnings With $148.4M Revenue
Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) is a commercial-stage biopharmaceutical company built around a highly focused mission: to develop and…
Seres Therapeutics (MCRB) Secures $3.6M in CARB-X Funding for Breakthrough SER-155 Program
Seres Therapeutics, Inc. (NASDAQ:MCRB) is a pioneer in the field of live biotherapeutic products, emerging from the earliest…
Nuvation Bio (NUVB) Receives $10 Analyst Target After 204-Patient Trial Milestone
Nuvation Bio Inc. (NYSE:NUVB) is a specialized biopharmaceutical company founded with the mission of developing transformative therapies for…
Medtronic (MDT) Reports $9 Billion Revenue Surge
Medtronic plc (NYSE:MDT) is one of the world’s largest, oldest, and most influential medical technology companies, with a…
Boston Scientific (BSX) Set for a 25% Rally? Analysts Predict $127.55 Price Target
Boston Scientific Corporation (NYSE:BSX) is one of the world’s leading medical technology companies, built on a history of…
Kazia Therapeutics (KZIA) Faces NASDAQ Delisting After Missing Compliance Deadline — Is This the End?
Kazia Therapeutics Limited (NASDAQ:KZIA) is an Australia-based biotechnology company dedicated to the development of innovative, targeted oncology therapies…
Olema Pharma (OLMA) Surges After Roche’s Phase 3 Win Validates Oral SERDs
Olema Pharmaceuticals Inc. (NASDAQ:OLMA) is a clinical-stage biotechnology company founded with a singular mission: to transform the treatment…
Is Fulcrum Therapeutics (FULC) the Next Rare-Disease Winner? New Data Says YES
Fulcrum Therapeutics Inc. (NASDAQ:FULC) has built its identity as a clinical-stage biopharmaceutical company committed to transforming the lives…